Why is Mukka Proteins falling/rising?

As of 20-Aug, Mukka Proteins Ltd is experiencing a decline in its stock price, currently at 27.40, reflecting a decrease of 0.38 or 1.37%. The stock has underperformed its sector today by 0.68%, and while it is higher than its 5-day moving average, it remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 1.58%, and it has seen a significant decline of 44.35% over the past year. Despite a healthy long-term growth rate in operating profit of 50.86%, the company has faced challenges, including a high Debt to EBITDA ratio of 4.36 times and negative results for the last six consecutive quarters, which have contributed to its recent price movement.
In the broader market context, Mukka Proteins' performance has been notably poor compared to the benchmark Sensex, which has gained 1.64% over the past week. The stock's year-to-date return of -33.25% starkly contrasts with the Sensex's positive return of 4.76%. Additionally, institutional investors have reduced their stake in the company by 0.65%, indicating a lack of confidence in its fundamentals. This declining participation, coupled with the company's inability to service debt effectively and the significant drop in net sales and profits, suggests a challenging environment for Mukka Proteins, further exacerbating its stock price decline.